EGFR and cancer: Considering that the ERBB family member ERBB3 was reported to recruit PI3Kβ and thereby drive PI3Kα inhibitor resistance in HER2‐amplified and PIK3CA mutant cancers [27], we hypothesized that ALK inhibition may similarly activate EGFR and thereby regulate PI3Kβ function.